Sunitinib malate is active against human urothelial carcinoma and enhances the activity of cisplatin in a preclinical model

Guru Sonpavde, Weiguo Jian, Hao Liu, Meng Fen Wu, Steven Shen, Seth P. Lerner

Research output: Contribution to journalArticlepeer-review

75 Scopus citations

Fingerprint

Dive into the research topics of 'Sunitinib malate is active against human urothelial carcinoma and enhances the activity of cisplatin in a preclinical model'. Together they form a unique fingerprint.

Medicine & Life Sciences